Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABPM Extension Study of Oral Testosterone Undecanoate in Hypogonadism
NCT04467697Phase 3Completed
- Sponsor
- Marius Pharmaceuticals
- Start
- Sep 2018
- Primary completion
- May 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of vilobelimab in Hypogonadism, sponsored by Marius Pharmaceuticals. Started Sep 2018; status: completed.
02
Drugs
vilobelimab
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT04467697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467697.